Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 19Thoracic 16Head & Neck 9CNS 3Gynecologic 2Breast 2Tumor-Agnostic 1Genitourinary 1Classical hematology 1

Conditions

Hepatic Veno-Occlusive Disease 1Colorectal Neoplasms 1Chemical and Drug Induced Liver Injury 1

Interventions

hetrombopag 2treosulfan 1fludarabine 1ferric carboxymaltose 1apixaban 1Vancomycin 1Therapeutics 1Teicoplanin 1Surgical Procedures, Operative 1S-Adenosylmethionine 1Rosuvastatin Calcium 1Rivaroxaban 1Ofloxacin 1Observation 1NF protocol 1Metronidazole 1Meropenem 1Melphalan 1Levofloxacin 1Lead 1Honey 1Heparin, Low-Molecular-Weight 1Dalteparin 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Blood Specimen Collection 1Aspirin 1Amikacin 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Surgical Procedures, Operative × Classical hematology × Clear all
NCT06258525 2026-05-06

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Cedars-Sinai Medical Center

Phase 2 Not yet recruiting
30 enrolled
Classical hematologyGastrointestinal

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡